These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 33226870)

  • 1. Familial Hypercholesterolemia: A Reportable Disorder.
    Kullo IJ
    Circulation; 2020 Nov; 142(21):1999-2001. PubMed ID: 33226870
    [No Abstract]   [Full Text] [Related]  

  • 2. Cascade genetic screening for familial hypercholesterolemia.
    Leren TP
    Clin Genet; 2004 Dec; 66(6):483-7. PubMed ID: 15521974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cascade Screening for Familial Hypercholesterolemia and the Use of Genetic Testing.
    Knowles JW; Rader DJ; Khoury MJ
    JAMA; 2017 Jul; 318(4):381-382. PubMed ID: 28742895
    [No Abstract]   [Full Text] [Related]  

  • 4. Lessening the Burden of Familial Hypercholesterolemia Using Health Information Technology.
    Safarova MS; Kullo IJ
    Circ Res; 2018 Jan; 122(1):26-27. PubMed ID: 29301842
    [No Abstract]   [Full Text] [Related]  

  • 5. [Screening for familial hypercholesterolemia].
    Cariou B; Krempf M
    Rev Prat; 2011 Oct; 61(8):1106-7. PubMed ID: 22135978
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical Genetic Testing for Familial Hypercholesterolemia: JACC Scientific Expert Panel.
    Sturm AC; Knowles JW; Gidding SS; Ahmad ZS; Ahmed CD; Ballantyne CM; Baum SJ; Bourbon M; Carrié A; Cuchel M; de Ferranti SD; Defesche JC; Freiberger T; Hershberger RE; Hovingh GK; Karayan L; Kastelein JJP; Kindt I; Lane SR; Leigh SE; Linton MF; Mata P; Neal WA; Nordestgaard BG; Santos RD; Harada-Shiba M; Sijbrands EJ; Stitziel NO; Yamashita S; Wilemon KA; Ledbetter DH; Rader DJ;
    J Am Coll Cardiol; 2018 Aug; 72(6):662-680. PubMed ID: 30071997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Present and the Future of Genetic Testing in Familial Hypercholesterolemia: Opportunities and Caveats.
    Hooper AJ; Burnett JR; Bell DA; Watts GF
    Curr Atheroscler Rep; 2018 May; 20(6):31. PubMed ID: 29779130
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and Treatment of Heterozygous Familial Hypercholesterolemia.
    McGowan MP; Hosseini Dehkordi SH; Moriarty PM; Duell PB
    J Am Heart Assoc; 2019 Dec; 8(24):e013225. PubMed ID: 31838973
    [No Abstract]   [Full Text] [Related]  

  • 9. Development of a motivational interviewing genetic counseling intervention to increase cascade cholesterol screening in families of children with familial hypercholesterolemia.
    Kruger V; Redlinger-Grosse K; Walters ST; Ash E; Cragun D; McCarthy Veach P; Zierhut HA
    J Genet Couns; 2019 Oct; 28(5):1059-1064. PubMed ID: 31273864
    [No Abstract]   [Full Text] [Related]  

  • 10. Decision to reject screening for familial hypercholesterolaemia is flawed.
    Wald DS; Martin AC
    Arch Dis Child; 2021 Jun; 106(6):525-526. PubMed ID: 32601084
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of registries and genetic databases in familial hypercholesterolemia.
    Kindt I; Mata P; Knowles JW
    Curr Opin Lipidol; 2017 Apr; 28(2):152-160. PubMed ID: 28169870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perspectives on Identifying and Treating Familial Hypercholesterolemia in Childhood.
    ; de Ferranti SD; Kazi DS; ; Bibbins-Domingo K; Daniels S; Howaniec B; Khera AV; Newman TB; Vernacchio L
    Clin Chem; 2021 Oct; 67(10):1312-1317. PubMed ID: 34491300
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of familial hypercholesterolemia in general practice using clinical diagnostic criteria or genetic testing as part of cascade genetic screening.
    Leren TP; Finborud TH; Manshaus TE; Ose L; Berge KE
    Community Genet; 2008; 11(1):26-35. PubMed ID: 18196915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hypercholesterolemia--epidemiology, diagnosis, and screening.
    Singh S; Bittner V
    Curr Atheroscler Rep; 2015; 17(2):482. PubMed ID: 25612857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of people with heterozygous familial hypercholesterolemia.
    Haase A; Goldberg AC
    Curr Opin Lipidol; 2012 Aug; 23(4):282-9. PubMed ID: 22801386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic screening and treatment in familial hypercholesterolemia].
    Leren TP; Tonstad S; Ose L
    Tidsskr Nor Laegeforen; 2001 May; 121(13):1635-6. PubMed ID: 11446055
    [No Abstract]   [Full Text] [Related]  

  • 17. Cascade screening for familial hypercholesterolemia: Practical consequences.
    Louter L; Defesche J; Roeters van Lennep J
    Atheroscler Suppl; 2017 Nov; 30():77-85. PubMed ID: 29096865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial hypercholesterolemia: is it time to separate monogenic from polygenic familial hypercholesterolemia?
    Brandts J; Dharmayat KI; Ray KK; Vallejo-Vaz AJ
    Curr Opin Lipidol; 2020 Jun; 31(3):111-118. PubMed ID: 32332432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A GENETIC VIEW OF FAMILIAL HYPERCHOLESTEROLEMIA].
    Matías-Pérez D; Pérez-Campos E; García-Montalvo IA
    Nutr Hosp; 2015 Dec; 32(6):2421-6. PubMed ID: 26667688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Family Recruitment in a Program of Genetic Cascade Screening for Familial Hypercholesterolemia.
    Izar MCO; Fonseca FAH
    Arq Bras Cardiol; 2018 Oct; 111(4):585-586. PubMed ID: 30365680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.